3 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... exacerbations Drug Class ... Dosing: 250 mcg tablet ... won’t have any clinical ... #Roflumilast #Indications
Cold Urticaria
Prevalence - 0.05% in the population
Disease onset - Mostly 2nd to 4th decades of life
Causes
decades of life Causes ... and clinical associations ... Disease trigger - Direct ... #rheumatology #comparison ... #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... ASA class If ... event, follow ACC algorithm ... Change in clinical ... the type of and indication